Add to ORKGThe prospective entry of generic dominated Indian pharmaceutical sector in the ambit of new technologies is likely to give filip to emergence of strong biopharmaceutical sector.It is pertinent in this context to draw a policy roadmap which takes into account sectoral dynamics and draws upon regional and international linkages. An appropriate balance between national system of innovation (NSI) and sectoral system of innovation (SSI) would determine trajactory of growth of this sector.NSI, SSI, Biopharmaceutical and India
In India, as in most developing countries, biotechnology was ushered in through public policy rather...
Integrating political, industrial and healthcare systems has been a major challenge for politics of ...
The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to ent...
To be competitive Indian pharmaceutical and biotechnology companies pursue both imitative and innova...
The impact of TRIPS agreement on the growth and technological capabilities of the Indian and emergin...
Over the last decade the Indian pharmaceutical industry has emerged as a leading supplier of generic...
To be competitive Indian pharmaceutical and biotechnology companies pursue both imitative and innova...
Over the last decade the Indian pharmaceutical industry has emerged as a leading supplier of generic...
Indian civilization developed a strong system of traditional medicine and was one of the first natio...
Bagchi-Sen S. and Lawton Smith H. Science, institutions, and markets: developments in the Indian bio...
Some industrially advanced developing countries have, in the last decades, built substantial pharmac...
Some industrially advanced developing countries have, in the last decades, built substantial pharmac...
The role of biotechnology in providing an alternate, more productive approach to new drug developmen...
Developing countries have traditionally been regarded as users of technology developed abroad. Durin...
AbstractGlobally, a large number of blockbuster biotherapeutic molecules are going off patent in the...
In India, as in most developing countries, biotechnology was ushered in through public policy rather...
Integrating political, industrial and healthcare systems has been a major challenge for politics of ...
The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to ent...
To be competitive Indian pharmaceutical and biotechnology companies pursue both imitative and innova...
The impact of TRIPS agreement on the growth and technological capabilities of the Indian and emergin...
Over the last decade the Indian pharmaceutical industry has emerged as a leading supplier of generic...
To be competitive Indian pharmaceutical and biotechnology companies pursue both imitative and innova...
Over the last decade the Indian pharmaceutical industry has emerged as a leading supplier of generic...
Indian civilization developed a strong system of traditional medicine and was one of the first natio...
Bagchi-Sen S. and Lawton Smith H. Science, institutions, and markets: developments in the Indian bio...
Some industrially advanced developing countries have, in the last decades, built substantial pharmac...
Some industrially advanced developing countries have, in the last decades, built substantial pharmac...
The role of biotechnology in providing an alternate, more productive approach to new drug developmen...
Developing countries have traditionally been regarded as users of technology developed abroad. Durin...
AbstractGlobally, a large number of blockbuster biotherapeutic molecules are going off patent in the...
In India, as in most developing countries, biotechnology was ushered in through public policy rather...
Integrating political, industrial and healthcare systems has been a major challenge for politics of ...
The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to ent...